Mary Caserta
Pediatric Infectious Diseases · Rochester, NYNPI 1861427569
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,032 of the $1,686 with a category attached, or 61.2%. Every reported general payment came from a single manufacturer, Pfizer.
Across 4 payments — averaging $421.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$2K
Across 85 payments — averaging $19,125 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$1.2M
- Merck$459K
What the payments were for
- Travel & lodging$1,03261%
- Food & beverage$65539%
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 4 | $1,686 |
How this compares
$1,686 in reported general payments places this provider in the 65th percentile of 73 pediatric infectious diseases providers in New York.
See all pediatric infectious diseases providers in New York →
Other pediatric infectious diseases in Rochester
- Brenda TesiniRochester$45K
- Geoffrey WeinbergRochester$7K
- Benjamin BriggsRochester$79
- Jennifer NayakRochester$28
- Joseph DomachowskeSyracuse$470K
- Jana ShawWatertown$346K
- Philip LarussaNew York$125K
- Lisa SaimanNew York$73K
- Leonard KrilovMineola$64K
- Margaret HammerschlagBrooklyn$33K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.